DNA Repair-Deficiency Disorders D049914

Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » DNA Repair-Deficiency Disorders

Description

Disorders resulting from defective DNA REPAIR processes or the associated cellular responses to DNA DAMAGE.   MeSH

Hierarchy View

Subtype Terms (11)

Ataxia Telangiectasia
28 drugs (25 approved, 3 experimental)

Bloom Syndrome
 

Cockayne Syndrome
1 approved drug

Colorectal Neoplasms, Hereditary Nonpolyposis
20 drugs (16 approved, 4 experimental)

Fanconi Anemia
50 drugs (26 approved, 24 experimental)

Li-Fraumeni Syndrome
1 approved drug

Nijmegen Breakage Syndrome
1 experimental drug

Rothmund-Thomson Syndrome
 

Severe Combined Immunodeficiency
39 drugs (23 approved, 16 experimental)

Werner Syndrome
2 drugs (1 approved, 1 experimental)

Xeroderma Pigmentosum
3 approved drugs


Phase 4 Indicated Drugs (1)

Phase 1 Indicated Drugs (2)


Organization Involved with Phase 1 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.